DZ Bank
SLNO

DZ Bank’s Soleno Therapeutics SLNO Stock Holding History

DZ Bank’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,920
Closed -$215K – 1060
2018
Q1 		$215K Buy
+7,920
New +$216K ﹤0.01% 923

Other funds holding SLNO

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

DZ Bank's SLNO Position: Q2 2018 in Review

DZ Bank sold out of Soleno Therapeutics (SLNO) in Q2 2018, closing a stake of 7,920 shares — an estimated $215K sold.

DZ Bank first reported a position in SLNO in Q1 2018 and held it in 1 quarter. The position peaked at $215K in Q1 2018. 17 funds tracked by Wall St. Rank hold SLNO as of Q2 2018.

  • DZ Bank reported no remaining Soleno Therapeutics position as of Q2 2018 after selling out during the quarter.
  • DZ Bank sold 7,920 Soleno Therapeutics shares in Q2 2018, an estimated $215K.
  • DZ Bank first reported a position in Soleno Therapeutics in Q1 2018 and held it in 1 quarter.
  • DZ Bank's Soleno Therapeutics position peaked at $215K in Q1 2018.
  • 17 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.